Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas

Recently, a novel classification for pulmonary adenocarcinomas (ADCs) was published, the cornerstone of which is the quantification of growth patterns. Data on reproducibility in the routine diagnostic setting are lacking. 100 constitutive cases of lung ADC resection specimens from our archives were classified independently by five pulmonary pathologists and two residents according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. The most frequent predominant pattern in our cohort was solid (37%), followed by acinar (35%), lepidic (20%), papillary (5%) and micropapillary (3%). &kgr;-values for the denomination of the predominant pattern revealed substantial agreement for pulmonary pathologists (&kgr;=0.44–0.72) and fair agreement for residents (&kgr;=0.38–0.47). Interobserver variability was significantly higher in cases with higher slide numbers (p=0.028) and was considerably reduced after training. Intraobserver variability was low (&kgr;=0.79–0.87). Papillary and micropapillary patterns were the most complicated patterns to evaluate, while evaluation of lepidic and solid tumour growth was straightforward. Our data imply that the novel classification of pulmonary ADC is applicable with acceptable interobserver variability if performed by specifically trained pathologists. Additional efforts are needed to harmonise the application of this novel and clinically important classification scheme of pulmonary ADC.

[1]  Jonathan I. Epstein,et al.  Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial. , 2011, Urology.

[2]  Michael Thomas,et al.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[4]  J. Coindre Grading of soft tissue sarcomas: review and update. , 2009, Archives of pathology & laboratory medicine.

[5]  Yang Xue-ning International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .

[6]  Lars Egevad,et al.  Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens , 2003, Virchows Archiv.

[7]  Jeffrey W. Clark,et al.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.

[8]  S. Hauptmann,et al.  Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Brambilla,et al.  The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  A. Nicholson,et al.  Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis , 2008, European Respiratory Journal.

[12]  Akihiko Yoshizawa,et al.  A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.

[13]  D. Wigle,et al.  Prospects for molecular staging of non-small-cell lung cancer from genomic alterations , 2010, Expert review of respiratory medicine.

[14]  S S Cross,et al.  Grading and scoring in histopathology , 1998, Histopathology.

[15]  M. Rubin,et al.  Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays , 2008, Journal of Cancer Research and Clinical Oncology.

[16]  Akihiko Yoshizawa,et al.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.

[17]  R Y Ball,et al.  A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility , 2006, Histopathology.

[18]  R. Rami-Porta,et al.  The New Tumor, Node, and Metastasis Staging System , 2011, Seminars in respiratory and critical care medicine.

[19]  S. Moss,et al.  A UK‐based investigation of inter‐ and intra‐observer reproducibility of Gleason grading of prostatic biopsies , 2006, Histopathology.

[20]  M. D. den Bakker,et al.  Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability , 2010, Histopathology.

[21]  O. O. Miller Lung cancer. , 1954, The Journal of the Kentucky State Medical Association.

[22]  C. Comin,et al.  EU–USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer , 2006, European Respiratory Journal.

[23]  Zoe Wainer,et al.  Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  Lin Huan,et al.  Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .

[25]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.